Undercurrent News page

Organobait featured in Undercurrent News

Kepley BioSystems is proud to be featured in a write up on Undercurrent News, a premiere website on the global seafood industry. The article, written by Ola Wietecha, discusses the impact that Organobait can potentially have on the ecosystem by reducing the demand on forage fish and on the industry at large.

Read more at undercurrentnews.com

The Anguillian

Kepley BioSystems Inc featured in The Anguillian newspaper

Kelpley BioSystems, and our founders Anthony Dellinger and Terry Brady, were recently featured in an article in The Anguillian newspaper. Read more here.

They write:

Late last week, it was announced that an important invention to help conserve a critical link in the food chain has been funded for final development by the US government. The lead inventor, Terry Brady, said, “I was able to think about it while walking on Shoal Bay, and my collaborators in North Carolina helped take it to the next level for us to apply for our patent.”
Kepley BioSystems, a North Carolina start-up, has been awarded a coveted National Science Foundation (NSF) Phase II grant for developing an alternative to help stem the continued depletion of wild “forage” fish (small species, e.g. sardines, menhaden, anchovies) using a patent-pending, synthetic crustacean bait (#14/659,710 and #PCT/US2015/2086). Crustacean fishing is a $66 billion global market that consumes over 18 million metric tons of bait fish for these traps at a cost of an estimated $20 billion per year. This technology promises to completely replace the use of fish to catch fish, lobster and crabs in this segment with a man-made and environmentally neutral alternative.
In addition to lobster and crab fishing, industrial net fishing for 35 million metric tons of forage fish per annum supplies commercial production in numerous sectors, including: agricultural additives; pig and chicken feed; pet food; fish farming (aquaculture); and Omega 3 supplement oil (with well-documented, collateral loss of dolphin and other unintended by-catch). Second only to the importance and biomass of plankton, forage fish also provide the sole food source for many other fish, mammals, and birds in every region of the world.
“It’s hardly a mystery to hear of depleted forage fish populations, with emaciated birds, seals, and whales featured in the news,” said Dr. Dellinger, president of Kepley BioSystems. “This NSF Phase II grant will support continued laboratory activities. In addition, we are planning extensive field testing to ensure the success of this ecologically urgent innovation.” The company is in an advanced stage of product development, and they will seek to further leverage this grant throughout scale up and commercialization by welcoming early investors in the coming months.

– Press Release

Thanks to The Anguillian for the article.

Kepley Biosystems Inc Receives NSF Phase II Grant

On behalf of our entire Kepley BioSystems team, I am pleased to inform everyone we have been awarded a National Science Foundation Phase II grant. Press release below:

NC Life Sciences Start-Up Awarded NSF Phase II Grant
Synthetic Alternative to Use of Wild Fish as Bait in a Multi-Billion Dollar Market

Greensboro, NC: Thursday, March 3, 2016

Kepley BioSystems, a North Carolina start-up, has been awarded a coveted National Science Foundation (NSF) Phase II SBIR grant for developing a synthetic, environmentally neutral alternative to help stem the continued depletion of wild fish; while at the same time, addressing a multi-billion dollar market. The grant has been awarded to the company after successfully competing for Phase I and IB NSF funding for research on a patent-pending, synthetic crustacean bait (#14/659,710 and ‪#‎PCT‬/US2015/2086). This grant will enable optimization of this technology to replace the use of wild fish stocks as the primary bait in commercial lobster and crab traps. Crustacean fishing is a $66 billion global market that consumes over 18 million metric tons of bait fish for these traps at a cost of an estimated $20 billion per year.

For more information, click here.

To download a PDF of this press release, click here.

Kepley Biosystems Incorporated awarded NSF SBIR Phase 1B for ocean-restoring technology

Online PR News – 16-June-2015 – June 16, 2015 Greensboro, N.C. – Greensboro, N.C., June 16, 2015 – Kepley Biosystems Incorporated (KBI) announced today that it has been awarded a SBIR Phase IB supplemental from the National Science Foundation for testing Organobait™, a synthetic bait that will benefit crustacean fishers and help restore oceanic health. Dr. Anthony Dellinger, President for the Company and Principal Investigator for the project said of the award: “The oceans and fish are in desperate need of new technologies and approaches that will help restore once healthy ecosystems.” One potential solution is a product KBI is developing called Organobait™ (pictured below). With research and development funding from the National Science Foundation (NSF), we are able to validate this alternative bait for catching crustaceans without the need of forage fish for crustacean trap baiting. Forage fish are vital to oceanic health, yet are globally overfished due to runaway industrial applications and plunder.

This NSF Phase 1B award is subsequent to a kickoff grant from the North Carolina’s Office of Science, Technology, and Innovation’s One N.C. Small Business Program and our NSF Phase I award. KBI was an academically inspired company coming from the laboratories of Professor Christopher Kepley, Joint School of Nanoscience and Nanotechonogy (University of N.C. at Greensboro & N.C. Agriculture & Technology).

Dr. Dellinger added, “Our early data has shown that Organobait™ can attract crustaceans to traps and likewise mitigate the excessive removal of forage fish from the ocean. We are fortunate to work with noteworthy crustacean fishers throughout the U.S., which have provided us with valuable infield scientific data and fishing feedback.

Contact person
Anthony Dellinger, Ph.D.
President of Kepley Biosystems Incorporated
adellinger@kepleybiosystems.com
– See more at: Online PR News